phrykt

Biomea Fusion, Inc. (BMEA): who owns it and who trades it

As of Nov 16, 2026, BMEA insiders reported 4 purchases worth $196K in the last 12 months. The largest buyer was Michael J.M. Hitchcock (CEO), with $99K. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Biomea Fusion

From the latest filings

Overall: more buying than selling. Insiders mostly bought. Funds and famous investors were close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns BMEA

59 funds and institutions reported BMEA shares worth $36.7M at the end of Q2 2026, about 35% of the company. The largest holder is FMR LLC (Fidelity) with 12.2%.

Funds and institutions (13F) 35%Everyone else 65%

10 largest owners, by share of the company

FMR LLC (Fidelity)12.2%
Vanguard Capital Management LLC3.9%
Marshall Wace, LLP2.8%
Aisling Capital Management LP2.8%
Renaissance Technologies LLC2.0%
Fideuram - Intesa Sanpaolo Private Banking S.p.a.1.0%
BlackRock, Inc.1.0%
Geode Capital Management, LLC1.0%
Susquehanna International Group, LLP0.8%
Mariner, LLC0.8%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
FMR LLC (Fidelity)8.81M12.19%$13MNo change
Vanguard Capital Management LLC2.83M3.91%$4.2M+9%
Marshall Wace, LLP2.05M2.84%$3M+71%
Aisling Capital Management LP2.05M2.83%$3MNo change
Renaissance Technologies LLC1.46M2.01%$2.1M+11%
Fideuram - Intesa Sanpaolo Private Banking S.p.a.723,1761.00%$1.1M+30%
BlackRock, Inc.715,4450.99%$1.1M+12%
Geode Capital Management, LLC708,8540.98%$1M+29%
Susquehanna International Group, LLP612,7350.85%$901K-3%
Mariner, LLC594,7260.82%$874K-9%
Jane Street Group, LLC458,2890.63%$674K+66%
UBS Group AG444,7280.62%$654K-14%
XTX Topco Ltd406,8790.56%$598K-23%
Two Sigma Investments, LP384,4590.53%$565K-1%
Morgan Stanley367,0210.51%$540K+6%
Vanguard Fiduciary Trust Co338,3450.47%$497K+1%
MAI Capital Management289,1000.40%$425K+224%
State Street Corp257,3150.36%$378K+24%
Gsa Capital Partners LLP216,0200.30%$318K+632%
LMR Partners LLP200,0000.28%$261KNo change

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, BMEA insiders reported $196K of open-market purchases and $0 of sales.

Purchases, 12 months
$196K
4 trades, 2 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
Dec 11, 2025
Filed Dec 15, 2025

Purchases and sales by month

$152K$152KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Dec 11, 2025Rainer M ErdtmannDirectorPurchase30,000$1.43$42.9KForm 4
Dec 2, 2025Michael J.M. HitchcockCEOPurchase100,000$0.99$99KForm 4
Dec 1, 2025Rainer M ErdtmannDirectorPurchase10,000$1.05$10.5KForm 4
Nov 28, 2025Rainer M ErdtmannDirectorPurchase40,000$1.10$44KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Michael J.M. HitchcockInterim CEO, Director$99K–Dec 2, 2025
Rainer M ErdtmannSee Remarks, Director$97.4K–Dec 11, 2025
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

BMEA short interest

Very high short interest. 20.9% of BMEA shares are sold short: about 1 share in 5. Over the last 12 reports the number of shares short went up 6%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 15.21M BMEA shares were sold short, 20.9% of the shares outstanding, down 3.2% from the report before. At the average daily volume of 1.80M shares, buying them all back would take about 8.4 trading days (days to cover).

Shares short, % of all shares

20.9%May 15Oct 3022.9%

Days to cover

8.4May 15Oct 3025.5

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202615.21M20.93%-3%1.80M8.4
Oct 15, 202615.71M21.68%+12%3.24M4.8
Sep 30, 202614.08M19.42%+6%2.49M5.7
Sep 15, 202613.22M18.24%+11%2.05M6.4
Aug 31, 202611.95M16.49%+22%2.41M5.0
Aug 14, 20269.82M13.55%-2%470,41920.9
Jul 31, 202610.02M13.82%-4%438,67522.8
Jul 15, 202610.45M14.45%-24%1.06M9.9
Jun 30, 202613.83M19.13%-1%947,63014.6
Jun 15, 202613.96M19.31%-4%1.11M12.5
May 29, 202614.48M20.03%+1%1.00M14.4
May 15, 202614.40M19.92%+0%1.36M10.6

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Biomea Fusion company events

Biomea Fusion filed 8 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Oct 14, 2026.

  1. Oct 14, 2026AnnouncementThe Company issued a press release titled, “Biomea Fusion Announces Phase 1 Results for BMF-650, its Investigational Next-Generation Oral Small Molecule GLP-1 Receptor Agonist.” A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.2 and is incorporated herein by… Filing
  2. Sep 22, 2026AnnouncementBiomea Fusion, Inc. updated the anticipated timing for topline results from the Company’s ongoing Phase I GLP-131 trial for BMF-650 in obese, otherwise healthy volunteers, which are now expected in October 2026. Filing
  3. Jun 11, 2026VoteReported shareholder vote results. Filing
  4. May 11, 2026ResultsReleased financial results. Filing
  5. Apr 28, 2026AnnouncementThe Company reported positive 52-week results from its Phase 2 COVALENT-112 trial evaluating the efficacy, safety, and tolerability of icovamenib in patients with type 1 diabetes. Filing
  6. Mar 24, 2026ResultsReleased financial results. Filing
  7. Feb 25, 2026AnnouncementShared information with investors. Filing
  8. Jan 14, 2026AnnouncementThe Company updated its corporate presentation to be used from time to time with investors, analysts and other third parties. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Biomea Fusion financials

Famous investors that hold BMEA

4 of the 50 well-known investors we track reported holding BMEA in their latest 13F filing. The largest position is Jim Simons's, worth $1.5M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 20261.16M$1.5M0.0%-20%
Ken Griffin · Citadel AdvisorsQ3 2026105,865$141K0.0%+136%
Steve Cohen · Point72 Asset ManagementQ3 202616,224$21.6K0.0%-51%
Israel Englander · Millennium ManagementQ3 202612,185$16.2K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Biomea Fusion, Inc. (BMEA) stock

Who owns the most BMEA stock?

The largest reported owner of Biomea Fusion, Inc. (BMEA) is FMR LLC (Fidelity), with 12.2% of the company. In total, 59 funds and institutions reported holding BMEA at the end of Q2 2026, together about 35% of the shares. See the largest owners.

Are BMEA insiders buying or selling?

In the last 12 months, BMEA insiders reported 4 open-market purchases worth $196K and no sales. The latest trade was on Dec 11, 2025. See every trade.

What is the short interest in BMEA?

As of Oct 30, 2026, 15.21M BMEA shares were sold short, 20.9% of the shares outstanding, down 3.2% from the report before. At the average daily volume of 1.80M shares, buying them all back would take about 8.4 trading days (days to cover). See the history.

Which famous investors hold BMEA?

4 of the 50 well-known investors we track reported BMEA in their latest 13F filing, including Jim Simons, Ken Griffin, Steve Cohen. The largest position is worth $1.5M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.